← All companies

ONO PHARMACEUTICAL CO., LTD.

4528 小野薬品工業株式会社
Annual Securities Report Consolidated Current period Pharmaceutical TSE Prime
Revenue
¥515.8bn+5.9% YoY
Operating income
¥92.2bn+54.4% YoY
Net income
¥69.8bn+39.4% YoY
Total assets
¥1.11tn
Compared with
Prior period
Fiscal year covered
2025-04-01 – 2026-03-31
EDINET document
S100YA20
Not disclosed in this filing: ordinary_income. Shown as a gap rather than estimated.

Latest quarter

Q1 cumulative (3 months) · disclosed 31 July 2026 · Consolidated · cumulative from the start of the fiscal year
ItemCumulativeYoY Company forecast (FY)Progress
Revenue¥116.2bn-8.9%¥455.0bn26%
Operating income¥30.7bn+39.4%¥94.0bn33%
Net income¥24.2bn+36.7%¥71.0bn34%
Progress is the cumulative figure divided by the company's own full-year forecast. Japanese companies publish and revise that forecast every quarter — it is their number, not an analyst estimate.

All reported figures

As filed · extracted from XBRL · no editorial adjustment · hover a row for the XBRL element it came from
ItemJapanesePeriodValue
Revenue売上高Current period¥515.8bn
Revenue売上高Prior period¥486.9bn
Operating income営業利益Current period¥92.2bn
Operating income営業利益Prior period¥59.7bn
Net income attributable to owners of parent親会社株主に帰属する当期純利益Current period¥69.8bn
Net income attributable to owners of parent親会社株主に帰属する当期純利益Prior period¥50.0bn
Net cash from operating activities営業活動によるキャッシュ・フローCurrent period¥136.8bn
Net cash from operating activities営業活動によるキャッシュ・フローPrior period¥82.5bn
Total assets総資産Current period¥1.11tn
Total assets総資産Prior period¥1.06tn
Net assets純資産Current period¥856.6bn
Net assets純資産Prior period¥788.2bn
Cash and cash equivalents現金及び現金同等物Current period¥237.0bn
Cash and cash equivalents現金及び現金同等物Prior period¥204.6bn
Basic EPS1株当たり当期純利益Current period¥148.49
Basic EPS1株当たり当期純利益Prior period¥106.55
Equity ratio自己資本比率Current period76.9%
Equity ratio自己資本比率Prior period73.5%
Employees従業員数Current period4,206
Employees従業員数Prior period4,287
Revenue growth YoY売上高 前年比Current period5.9%
Operating income growth YoY営業利益 前年比Current period54.4%
Net income growth YoY純利益 前年比Current period39.4%
Operating margin営業利益率Current period17.9%
Net margin純利益率Current period13.5%

View the original filing on EDINET →